<DOC>
	<DOCNO>NCT03019263</DOCNO>
	<brief_summary>Menopause usually associate increase body weight , change body composition fat distribution large number cardio-metabolic change , hypertension , reduction insulin-sensitivity dyslipidaemia . The first-line strategy complication modification dietary habit lifestyle term physical activity . Besides , also grow interest complementary therapy ( i.e . nutraceuticals ) use alone combination achieve consistent result . In context , preliminary evidence support potential role compound vegetal origin berberine , chlorogenic acid tocotrienols . However , support use , evidence good quality trial limit .</brief_summary>
	<brief_title>Berberine , Chlorogenic Acid Tocotrienols Menopause-associated Dyslipidemia</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<criteria>LDL cholesterol &gt; 100 mg/dL Written inform consent available Use drug affect blood lipid Hormone replacement therapy Adherence weigh loss diet previous 6 month Cancer diagnosis Known thyroid , liver , renal muscle diseases Any medical surgical condition could lead inconstant adhesion protocol</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>